In the News: Bruce Merenstein’s Role as Special Master and Mediator in Avandia Fee Dispute

Several news organizations have reported on the work of Schnader partner Bruce P. Merenstein with regard to his role as special master and mediator in the consolidated Avandia marketing and product liability litigation against GlaxoSmithKline.

Bloomberg: “Glaxo Plaintiff Lawyers Settle Dispute Over $143 Million“

Law360: “Attorneys Agree to $143 million Fee Split in $2.3 billion Avandia MDL“

Law.com: “Attorneys Settle Objections to Distribution Of $144 Million in Avandia Legal Fees“